Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Chavakis Website

Triantafyllos Chavakis, M.D., Ph.D.

Experimental Immunology Branch
Head, Inflammation Biology Section
Investigator
National Cancer Institute
Building 10, Room 5B17
Bethesda, MD 20892
Phone:  
301-451-2104
Fax:  
301-496-0887
E-Mail:  
chavakist@mail.nih.gov

Biography

Dr. Chavakis received his MD degree from the university Giessen, Germany and his doctorate degree under the mentorship of Prof. K.T. Preissner at the Max-Planck-Institute Bad Nauheim and at the Biochemistry Institute, University Giessen, Germany. He received clinical training in internal medicine at the universities Giessen and Heidelberg, Germany. He was a research group leader at the university Heidelberg, Germany, prior to joining the Experimental Immunology Branch in 2005.

Research

(A) Molecular mechanisms of inflammatory cell recruitment in innate immunity and autoimmunity.

As an immediate response towards infection or injury, or during autoimmunity, leukocytes extravasate into the site of inflammation. This coordinated multi-step sequence of adhesive events requires the upregulation and/or activation of various adhesion receptors on the surface of the leukocytes and the endothelium.

1) A focus of this laboratory is to understand how beta2-integrin-dependent interactions of leukocytes are regulated in inflammation and autoimmunity.

2) We are interested in the regulation of the endothelial barrier integrity. We characterize the function of junctional-adhesion molecule-C (JAM-C) in the regulation of endothelial junctions as well as in leukocyte transmigration and recruitment.


(B) Another research focus of the lab is the crosstalk between inflammation and angiogenesis. Here, we conduct studies analyzing the role of components of the innate immunity, such as inflammatory cells or anti-microbial peptides (e.g. defensins) as potent modulators of endothelial biology during the angiogenic process.


This page was last updated on 11/12/2008.